{"date":"2026-01-28","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-3176-2026-01-28-2010-qmpqzy","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-01-28","time":"20:10:02","subject":"開發中新藥OBP-301進度更新","clause":"第53款","fact_date":"2026-01-28","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-01-28 20:10，「開發中新藥OBP-301進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-01-28-1849-oytxl5","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-01-28","time":"18:49:50","subject":"本公司取得衛生福利部同意臨床試驗計畫書變更申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-01-28 18:49，「本公司取得衛生福利部同意臨床試驗計畫書變更申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-01-28-1737-11b1948","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-01-28","time":"17:37:53","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-01-28 17:37，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-01-28-1709-18li957","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-01-28","time":"17:09:58","subject":"代重要子公司台灣永生公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-01-28 17:09，「代重要子公司台灣永生公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-01-28-1643-1i9e80g","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-01-28","time":"16:43:15","subject":"公告本公司法人董事行政院國家發展基金管理會改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-01-28 16:43，「公告本公司法人董事行政院國家發展基金管理會改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-01-28-1621-1f7tf35","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-28","time":"16:21:01","subject":"公告本公司114年12月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-01-28","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-01-28 16:21，「公告本公司114年12月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-01-28-1620-tvrhm1","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-01-28","time":"16:20:31","subject":"本公司檢測試劑DNlite-DKD uPTM-FetA ELISA Kit獲得斯里蘭卡主管機關核發上巿許可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-01-28 16:20，「本公司檢測試劑DNlite-DKD uPTM-FetA ELISA Kit獲得斯里蘭卡主管機關核發上巿許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-01-28-1537-ps7z81","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-01-28","time":"15:37:40","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-01-28 15:37，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-01-28-1455-qrsqda","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-01-28","time":"14:55:02","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-01-28 14:55，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}